CTOs on the Move

Routehappy

www.routehappy.com

 
We`re an experienced team of aviation, data, and web app geeks from the online travel industry and other walks of life who decided flight search was too focused on price and schedule, despite the breadth of product differences available today. So we created the first of its kind merchandising content platform for flight shopping. We think flyers need better information when they shop, and that airlines and distributors deserve a platform to differentiate and better monetize their offerings. Our Scores & Amenities and Routehappy Hub products are solving the current flight shopping problem, providing data, content and tools all focused on ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

NotSolo

NotSolo is a Tucson, AZ-based company in the Business Services sector.

Pacific Rim Investigative Svc

Pacific Rim Investigative Svc is a Corona, CA-based company in the Business Services sector.

Soundworks Inc

Soundworks Inc is a Taos, NM-based company in the Business Services sector.

Enertel Advisors

CARB-X

CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership dedicated to accelerating early development antibacterial R&D to address the rising global threat of drug-resistant bacteria. CARB-X is led by Boston University and its funding is provided by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services; the Wellcome Trust, a global charity based in the UK; Germanys Federal Ministry of Education and Research (BMBF); the UK Department of Health and Social Cares Global Antimicrobial Resistance Innovation Fund (UK GAMRIF); the Bill & Melinda Gates Foundation, and with in-kind support from National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH) within the HHS. CARB-X is investing more than $500 million from 2016-2021 to support innovative antibiotics and other therapeutics, vaccines and rapid diagnostics. CARB-X supports the worlds largest and most innovative pipeline of preclinical products against drug-resistant infections. CARB-X focuses exclusively on high priority drug-resistant bacteria, especially Gram-negatives. CARB-X is headquartered at Boston University School of Law.